Sudip Bandyopadhyay of Inditrade Capital discusses the positive outlook for the Indian pharma sector following the easing of tariff concerns. He highlights Sun Pharma’s promising developments and Glenmark’s landmark R&D deal. Bandyopadhyay also notes the expected price hike in the steel industry due to increased global demand, while emphasizing company-specific uncertainties like JSW Steel’s Bhushan Steel strategy.
Parag Parikh Flexi Cap and ICICI Pru Large Cap among 17 equity mutual funds that receive over Rs 1,000 crore inflow in November
A top-inflow equity flexi-cap fund that drew strong investor interest in November as part of broad robust net inflows into India’s equity mutual funds.
December 13, 2025